S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
"This Could be the Biggest Stock Story of 2023" (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New Breakthrough "Living Software" Has Been… (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
"This Could be the Biggest Stock Story of 2023" (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New Breakthrough "Living Software" Has Been… (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
"This Could be the Biggest Stock Story of 2023" (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New Breakthrough "Living Software" Has Been… (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
"This Could be the Biggest Stock Story of 2023" (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New Breakthrough "Living Software" Has Been… (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
NASDAQ:ABCM

Abcam (ABCM) Stock Forecast, Price & News

$22.55
-0.04 (-0.18%)
(As of 09/22/2023 ET)
Compare
Today's Range
$22.55
$22.65
50-Day Range
$21.54
$23.89
52-Week Range
$12.48
$25.32
Volume
10.46 million shs
Average Volume
10.55 million shs
Market Capitalization
$5.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

Abcam MarketRank™ Forecast

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
2.0% Upside
$23.00 Price Target
Short Interest
Healthy
0.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.20mentions of Abcam in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
29.55%
From $0.44 to $0.57 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars

Medical Sector

666th out of 965 stocks

Biological Products, Except Diagnostic Industry

108th out of 160 stocks


ABCM stock logo

About Abcam (NASDAQ:ABCM) Stock

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

ABCM Price History

ABCM Stock News Headlines

Abcam (NASDAQ:ABCM) Sees Unusually-High Trading Volume
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Short Interest in Abcam plc (NASDAQ:ABCM) Drops By 5.3%
Abcam (NASDAQ:ABCM) Sees Strong Trading Volume
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
ABCAM INVESTOR ALERT by the Former Attorney...
Bank of America Securities Remains a Buy on Abcam (ABCM)
Abcam Plc (NASDAQ: ABCM)
Here’s Why Abcam plc (ABCM) Outperformed in Q2
Are Medical Stocks Lagging Abcam (ABCM) This Year?
Are Medical Stocks Lagging Abcam (ABCM) This Year?
Abcam plc: All Resolutions Withdrawn at Abcam's EGM
See More Headlines
Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCM Company Calendar

Today
9/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABCM
Fax
N/A
Employees
1,760
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$23.00
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+2.0%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$447.49 million
Cash Flow
$0.60 per share
Book Value
$3.92 per share

Miscellaneous

Free Float
213,842,000
Market Cap
$5.17 billion
Optionable
Not Optionable
Beta
0.93
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 55)
    M.B.A., M.S., MBA, MS, CEO & Exec. Director
    Comp: $1.19M
  • Mr. Michael Shaun Baldock B.A. (Age 59)
    CFO & Director
    Comp: $884.64k
  • Marc Leigh Russell Perkins
    Gen. Counsel & Company Sec.
  • Emma Sceats
    Sr. VP of Sales & Marketing
  • Mr. Nick Skinner
    Sr. VP of HR
  • Ms. Alejandra Solache Ph.D.
    Sr. VP of R&D
  • Mr. John Baker
    Sr. VP of Supply Chain & Manufacturing
  • Juan Carlos Sacristan
    Sr. VP of Data & Digital













ABCM Stock - Frequently Asked Questions

Should I buy or sell Abcam stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ABCM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABCM, but not buy additional shares or sell existing shares.
View ABCM analyst ratings
or view top-rated stocks.

What is Abcam's stock price forecast for 2023?

6 analysts have issued 1 year price targets for Abcam's stock. Their ABCM share price forecasts range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next year. This suggests a possible upside of 2.0% from the stock's current price.
View analysts price targets for ABCM
or view top-rated stocks among Wall Street analysts.

How have ABCM shares performed in 2023?

Abcam's stock was trading at $15.56 at the start of the year. Since then, ABCM shares have increased by 44.9% and is now trading at $22.55.
View the best growth stocks for 2023 here
.

Are investors shorting Abcam?

Abcam saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 1,790,000 shares, a decrease of 5.3% from the August 15th total of 1,890,000 shares. Based on an average daily trading volume, of 4,320,000 shares, the short-interest ratio is currently 0.4 days.
View Abcam's Short Interest
.

What ETFs hold Abcam's stock?
What guidance has Abcam issued on next quarter's earnings?

Abcam updated its earnings guidance on Tuesday, June, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $525.50 million-$550.53 million.

When did Abcam IPO?

(ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at a price of $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair served as the underwriters for the IPO.

What is Abcam's stock symbol?

Abcam trades on the NASDAQ under the ticker symbol "ABCM."

Who are Abcam's major shareholders?

Abcam's stock is owned by many different institutional and retail investors. Top institutional shareholders include Durable Capital Partners LP (6.27%), Harding Loevner LP (4.66%), Brown Capital Management LLC (4.34%), Baillie Gifford & Co. (3.56%), Brown Advisory Inc. (2.84%) and Bank of New York Mellon Corp (2.27%).

How do I buy shares of Abcam?

Shares of ABCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Abcam's stock price today?

One share of ABCM stock can currently be purchased for approximately $22.55.

How much money does Abcam make?

Abcam (NASDAQ:ABCM) has a market capitalization of $5.17 billion and generates $447.49 million in revenue each year.

How many employees does Abcam have?

The company employs 1,760 workers across the globe.

How can I contact Abcam?

The official website for the company is www.abcam.com. The company can be reached via phone at 44-0-12-2369-6000 or via email at investor.relations@abcam.com.

This page (NASDAQ:ABCM) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -